Definitive Contract 75F40122C00123
Award Date
9/27/22
Potential Completion Date
9/29/24
Potential Value
$300K
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
NAICS Category
611310 - Colleges, Universities, and Professional Schools
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
College Station, TX 77843, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
165
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Texas A&M AgriLife Research, a division of the Texas A&M University System, for conducting inspections of animal food manufacturing facilities. The contract is valued at $1,085,651.79 and has an ultimate completion date of September 29, 2026. The contract requires Texas A&M AgriLife Research to perform inspections to determine compliance with regulations regarding medicated feeds,...
The Department of Health and Human Services Food and Drug Administration awarded a $247,100 time and materials purchase order contract to Texas A&M Agrilife Research of College Station, Texas. The contract is for a systematic review of contaminant composition in human milk and infant formula to be performed from September 2023 through December 2024. As indicated in the attached notice of intent, the FDA is sole sourcing this requirement to Texas A&M Agrilife Research based on its...
This federal contract award, valued at $3,155,744.38, was issued by the Food and Drug Administration (FDA) to Texas State University. The contract is a delivery order with a cost-no-fee pricing type, and has an ultimate completion date of May 29, 2026. Texas State University, a public research university recognized as a Hispanic-Serving Institution, will provide a range of technical services, research, training, and educational support to the FDA through this contract. The contract does not have...
This federal contract award, valued at $6,038,686.00, was issued by the Food and Drug Administration (FDA) to the Massachusetts Institute of Technology (MIT) to address the ongoing growth in continuous manufacturing within cell lines. The award is part of the FDA's Broad Agency Announcement (BAA) program, which funds extramural research and development to support regulatory science and innovation. The BAA solicitation did not have a set-aside designation. Through this contract, MIT will...
This is a $400,000.00 Firm Fixed Price Definitive Contract awarded by the Food and Drug Administration (FDA) to the Regents of the University of Michigan. The contract is intended to advance the science of in vitro, animal model, pharmacokinetic studies, and/or real-world evidence studies to facilitate drug development, including studies focused on antimicrobial resistance and drug development for specific pathogens. This contract is not associated with a set-aside designation. The contract work...
This is a $116,803.22 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to New Mexico State University (NMSU) for animal food inspection services. The contract supports inspections of animal food manufacturing facilities to determine compliance with regulations related to medicated feeds, the Food Safety Modernization Act Produce Safety Rule, and feed-related Bovine Spongiform Encephalopathy requirements. NMSU, a Hispanic-serving land grant institution, is...
This is a $515,769.89 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA) to Universitat ST. Gallen, a foreign government educational entity, to conduct research and develop tools to strengthen post-market surveillance of FDA-regulated products. The objective is to apply advanced analytics and hybrid artificial intelligence to improve risk identification. This contract is part of the FDA's Fiscal Year 2025 Broad Agency Announcement (BAA) for Advanced Research...
This is a federal contract award from the Department of Homeland Security Countering Weapons of Mass Destruction to Texas A&M Agrilife Research, a division of The Texas A&M University System. The $479,520.23 Delivery Order contract, which has a completion date of December 19, 2020, is for research and services related to Infectious Animal Diseases (IIAD). The contract is not set aside. As a land grant institution, Texas A&M Agrilife Research has a history of federal prime contracts...
Landrau Scientific Innovations LLC was awarded a $567,980 firm fixed price definitive contract by the Department of Health and Human Services Food and Drug Administration to support the agency's Broad Agency Announcement PMQWP#237. This BAA seeks advanced research and development proposals to evaluate critical process parameters for the preparation of amphotericin B that influence toxicity, advancing the FDA's regulatory science and innovation goals. The prime contractor will conduct work at its...
This federal contract award, valued at $699,713.00, was issued by the Centers for Disease Control and Prevention (CDC) to Texas A&M AgriLife Research, a component of the Texas A&M University System. The contract, which does not have a set-aside designation, is for work under the CDC's 2020 Broad Agency Announcement (BAA) Topic 2.1. The contract is a definitive, firm fixed-price agreement with a performance period ending on December 31, 2023. Texas A&M AgriLife Research is a state...